E. Talor

发表

CEL-2000: A therapeutic vaccine for rheumatoid arthritis arrests disease development and alters serum cytokine/chemokine patterns in the bovine collagen type II induced arthritis in the DBA mouse model.

K. Rosenthal, A. Bendele, D. Zimmerman, 2010, International immunopharmacology.

Hypothesis: the aging paradox and autoimmune disease.

N. Rose, E. Talor, 1991, Autoimmunity.

Antigen-activated dendritic cells ameliorate influenza A infections.

K. Subbarao, K. Boonnak, M. Orandle, 2013, The Journal of clinical investigation.

Antigen‐Specific Immunoregulation and Autoimmune Thyroiditis a

N. Rose, E. Talor, 1991, Annals of the New York Academy of Sciences.

The induction of antigen-specific thymic regulatory cells in the mouse.

N. Rose, E. Talor, 1988, Cellular immunology.

Cells involved in the immune response. XXXIV: Suppressor cells in the thymus of the immunized rabbit capable of secreting a factor which can suppress the secretion of antibodies from antibody-forming cells in vitro.

M. Richter, E. Talor, 1986, Clinical immunology and immunopathology.

Leukocyte Interleukin, Inj. (LI) augmentation of natural killer cells and cytolytic T-lymphocytes.

R. Sidwell, R. Warren, M. Chirigos, 1995, Immunopharmacology and immunotoxicology.

L.E.A.P.S. heteroconjugate is able to prevent and treat experimental autoimmune myocarditis by altering trafficking of autoaggressive cells to the heart.

M. Kimura, N. Rose, D. Čiháková, 2008, International immunopharmacology.

The vaccine conundrum

K. Rosenthal, D. Zimmerman, E. Talor, 2007 .

Cells involved in the immune response. XXXV. The antigen-specific antibody response in the rabbit is suppressed by thymocytes of allogeneic immunized rabbits (ITSC) and by the non-toxic suppressor factor (ITSF) secreted by these thymocytes.

M. Richter, E. Talor, 1988, Clinical immunology and immunopathology.

Neoadjuvant immunotherapy of oral squamous cell carcinoma modulates intratumoral CD4/CD8 ratio and tumor microenvironment: a multicenter phase II clinical trial.

B. Döme, J. Tímár, É. Remenár, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Suppressor factors of non-T-cell origin in the regulation of humoral immune response in humans

M. Richter, E. Talor, 1988 .

Immunologic approaches to the treatment of prostate cancer.

G. Matyas, D. Harris, L. Gomella, 1999, Seminars in oncology.

T-cell derived suppressor factors in the regulation of humoral immunity

M. Richter, E. Talor, 1988 .

LEAPS therapeutic vaccines as antigen specific suppressors of inflammation in infectious and autoimmune diseases.

K. Rosenthal, D. Zimmerman, Harold L Steiner, 2012, Journal of vaccines & vaccination.

Induction of cross clade reactive specific antibodies in mice by conjugates of HGP-30 (peptide analog of HIV-1(SF2) p17) and peptide segments of human beta-2-microglobulin or MHC II beta chain.

M. Siwek, J. P. Lloyd, P. Sarin, 2001, Vaccine.

Cells Involved in the Immune Response XXXVII. Antigen‐Specific Suppressor Cells, Capable of Secreting an Antigen‐Specific Suppressor Factor, Migrate from the Thymus to the Spleen Following Primary Immunization

M. Richter, E. Talor, I. Trudel, 1990, Scandinavian journal of immunology.

A non-cytotoxic suppressor of immunoglobulin synthesis and secretion by B cells of normal humans and patients with rheumatoid arthritis and systemic lupus erythematosus.

M. Richter, C. Jodouin, H. Kaplan, 1991, Autoimmunity.

Antigen-activated dendritic cells ameliorate influenza A infections.

K. Subbarao, K. Boonnak, M. Orandle, 2020, The Journal of clinical investigation.